Document is current
Any future updates will be listed below
-
Authors
Zou, Penglin
Fan, Gaoxiang
Li, Zheng
Tao, Yuchen
Jia, Chao
Liang, Hongmei
Tian, Ruhui
Shi, Qiusheng
Hu, Jianlin
Wu, Rong
-
Funding
Funding for this research was provided by:
the National Key Research and Development Program of China (2022YFC2702700, 2022YFC2702700, 2022YFC2702700, 2022YFC2702700, 2022YFC2702700, 2022YFC2702700, 2022YFC2702700, 2022YFC2702700, 2022YFC2702700, 2022YFC2702700)
the Clinical Research Plan of SHDC (SHDC2020CR2071B, SHDC2020CR2071B, SHDC2020CR2071B, SHDC2020CR2071B, SHDC2020CR2071B, SHDC2020CR2071B, SHDC2020CR2071B, SHDC2020CR2071B, SHDC2020CR2071B, SHDC2020CR2071B)
- License Information
-
More Information
Article History
Received: 5 October 2024
Accepted: 31 December 2024
First Online: 23 January 2025
Declarations
:
: The present study protocol was reviewed and approved by the Institutional Ethical Review Committee of Shanghai General Hospital (ID: 2020KY139 and [2022]115). All patients provided written informed consent. The trial was registered with the Chinese Clinical Trial Registry (ID: ChiCTR2000036241).
: Not applicable.
: The authors declare no competing interests.
